|
|
|
Insider
Information: |
Wysenski Nancy |
Relationship: |
Director |
City: |
Chatsworth |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
93,398 |
|
Indirect Shares
|
11,242 |
|
|
Direct
Value |
$16,259,638 |
|
|
Indirect Value
|
$263,063 |
|
|
Total
Shares |
104,640 |
|
|
Total
Value |
$16,522,701 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-12.4%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Endo Health Solutions Inc |
ENDP |
Chief Operating Officer |
2009-02-26 |
13,054 |
2008-02-21 |
0 |
Premium* |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Chief Commercial ... |
2012-05-14 |
32,232 |
2009-12-09 |
0 |
Premium* |
|
Inovio Biomedical Corp |
INO |
Director |
2016-05-08 |
5,000 |
2016-05-08 |
0 |
Premium* |
|
Dova Pharmaceuticals, Inc. |
DOVA |
Director |
2019-11-12 |
0 |
2019-02-05 |
0 |
Premium* |
|
Alkermes Plc |
ALKS |
Director |
2023-07-07 |
20,356 |
2023-07-07 |
11,242 |
Premium* |
|
Cytokinetics Inc |
CYTK |
Director |
2024-05-15 |
22,756 |
2021-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
42 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CYTK |
Cytokinetics Inc |
Director |
|
2023-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
16,671 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2023-07-03 |
4 |
A |
$33.36 |
$6,238 |
D/D |
187 |
16,858 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2023-10-02 |
4 |
A |
$27.88 |
$6,245 |
D/D |
224 |
17,082 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2024-01-02 |
4 |
A |
$84.12 |
$6,225 |
D/D |
74 |
17,156 |
0 |
- |
|
CYTK |
Cytokinetics Inc |
Director |
|
2024-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,600 |
22,756 |
0 |
- |
|
DOVA |
Dova Pharmaceuticals, Inc... |
Director |
|
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
6,274 |
6,274 |
0 |
- |
|
DOVA |
Dova Pharmaceuticals, Inc... |
Director |
|
2019-11-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,274) |
0 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
Chief Operating Officer |
|
2008-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,466 |
4,466 |
0 |
- |
|
ENDP |
Endo Health Solutions Inc |
Chief Operating Officer |
|
2009-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
13,054 |
13,054 |
0 |
- |
|
INO |
Inovio Biomedical Corp |
Director |
|
2016-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Commercial Officer |
|
2009-12-09 |
4 |
A |
$0.01 |
$200 |
D/D |
20,000 |
20,000 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP & Chief Commercial Officer |
|
2011-02-03 |
4 |
A |
$0.01 |
$121 |
D/D |
12,084 |
32,084 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2011-11-15 |
4 |
AS |
$29.77 |
$18,041 |
D/D |
(606) |
32,935 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2011-12-12 |
4 |
AS |
$28.90 |
$144,500 |
D/D |
(5,000) |
27,935 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2012-01-19 |
4 |
AS |
$37.00 |
$223,554 |
D/D |
(6,042) |
21,893 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2012-05-14 |
4 |
AS |
$64.27 |
$11,568,872 |
D/D |
(180,000) |
32,232 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2012-05-14 |
4 |
OE |
$37.86 |
$7,134,605 |
D/D |
180,000 |
212,232 |
0 |
- |
|
42 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|